HealthTell Opens in Innovations Incubator

Chandler, AZ—HealthTell Inc., a new biotechnology start-up company, is expanding its operations to the Innovations Incubator in Chandler.  HealthTell has developed a system for providing “immunosignatures” for early screening and diagnosis of multiple diseases such as cancer and Alzheimer’s.Continue reading

NEA’s David Mott on what VC firm’s $2.6B fund means for biotech (biotechVC)

New Enterprise   Associates   packs financial firepower like few other venture capital outfits today,   particularly those investing in biotech. Fresh off closing a diversified   venture fund of $2.6 billion revealed in July, NEA is expected to spend   roughly a third of its capital from the fund on healthcare investments   primarily in the biopharma industry, General Partner David Mott   (who sold MedImmune to   AstraZeneca ($AZN)   for $15.6 billion in 2007), told FierceBiotech.Continue reading

Living with an Artificial Heart

SynCardia Publishes 1st Brochure for Total Artificial Heart Patients & Their Caregivers

12-Page Resource Describes How the Total Artificial Heart Works, What to Expect Before & After Surgery and the Steps to Patient Discharge Using the Freedom® DriverContinue reading